By Natalia Gurevich, SWHR Communications Intern
Post-menopause, hormonal changes can lead to a wide range of health issues – issues we’ve covered throughout our Hormones Across the Lifespan series, like hormone therapy, sexual health, and genitourinary syndrome of menopause (GSM).
An estimated 32 million women in the U.S. suffer from GSM. That’s approximately 40 to 50 percent of all women, who experience symptoms of GSM. Only 7 percent of women receive the proper treatment (a low dose of vaginal estrogen), even though over 80 to 90 percent see improvement within a few weeks.
GSM is an incredibly common condition, but it is rarely discussed, and few women seek treatment. Typically associated with menopause, especially when estrogen levels decrease, GSM can cause issues with the vagina, urethra, and bladder. SWHR and the National Association of Nurse Practitioners in Women’s Health (NPWH) have partnered together to share information about GSM.
SWHR and NPWH have put together information designed to help women and their health care providers learn more about the condition as easily and comfortably as possible. If you or someone you know is affected by GSM, learn more about the condition with SWHR and NPWH’s factsheet here. If you would like to speak to your healthcare provider about GSM, but don’t know where to start, visit here.
The Society for Women’s Health Research (SWHR ®) is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education.